Conformational analysis of synthetic heparin-like oligosaccharides containing α-L-idopyranosyluronic acid†

High-field NMR spectroscopy of synthetic heparin-like di- and trisaccharides has afforded a complete set of inter-proton-coupling data on α-L-idopyranosyluronic acid, which have been used for conformational analysis. These data lead to the conclusion that α-L-iduronic acid may display considerable conformational freedom including 1C4, 4C1 and 2S0 (e.g. compound 1) conformers. The 2-O-sulphate substituent at iduronic acid tends to stabilize the 1C4 conformation (e.g. compounds 2 and 4). In addition carbohydrate substituents at position 4 hinder the 4C1 conformation (e.g. compound 3a,b versus 1). Furthermore, the conformation of α-L-idopyranosyluronic acid 2-sulphate is affected seriously by the substituent at position 2 of the non-reducing glucosamine residue. Thus the presence of an ammonium group (i.e. compound 7) leads to unexpected deformation of the 1C4 form of iduronic acid, whereas a sulphamino substituent at this position (e.g. compound 5a,b) brings about the 2S0 skew boat conformation. The iduronic acid moiety of a trisaccharide (compound 6), which represents a part of the anti-thrombin III-binding site of heparin, shows conformational preference for the 2S0 form in aqueous solution under low ionic conditions. However, increasing the ionic strength (e.g. 3 M NaCl) causes the conformational equilibrium to incline towards the 1C4 chair conformer. This feature may be indicative for the mechanism of conformational control as exerted by the AT-III protein upon heparin binding. Several molecular models of preferred conformers have been constructed; Nuclear Overhauser Enhancement data, exo-anomeric effect and Van der Waals interactions have been taken into account.

[1]  Massimo Ragazzi,et al.  A force‐field study of the conformational characteristics of the iduronate ring , 1986, Journal of computational chemistry.

[2]  C. V. Boeckel,et al.  Synthesis of an antithrombin binding heparin-like pentasaccharide lacking 6-0 sulphate at its reducing end. , 1986 .

[3]  C. V. Boeckel,et al.  Synthesis of a Pentasaccharide Corresponding to the Antithrombin III Binding Fragment of Heparin , 1985 .

[4]  H. Gillier-Pandraud,et al.  Structure cristalline du 2-acétamido-1,3,6-tri-O-acétyl-2-désoxy-4-O-(2,3,4,6-tétra-O-acétyl-α-l-idopyranosyl)-α-d-glucopyranose , 1985 .

[5]  P. Sanderson,et al.  N.m.r. studies of the disulphated disaccharide obtained by degradation of bovine lung heparin with nitrous acid. , 1985, Carbohydrate research.

[6]  G. Torri,et al.  Mono- and bidimensional 500 MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue. , 1985, Biochemical and biophysical research communications.

[7]  B. Casu,et al.  Structure and biological activity of heparin. , 1985, Advances in carbohydrate chemistry and biochemistry.

[8]  G. Torri,et al.  Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III , 1984 .

[9]  T. Ono,et al.  Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Rosenberg.  The Function and Structure of the Heparin Molecule , 1983 .

[11]  G. Villanueva,et al.  Refolding properties of antithrombin III. Mechanism of binding to heparin. , 1983, The Journal of biological chemistry.

[12]  R. Langer,et al.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. , 1983, Science.

[13]  D. Tollefsen,et al.  Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. , 1982, The Journal of biological chemistry.

[14]  U Lindahl,et al.  Further characterization of the antithrombin-binding sequence in heparin. , 1982, Carbohydrate research.

[15]  J. Fareed,et al.  STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARIN , 1981, Annals of the New York Academy of Sciences.

[16]  Anthony A. Thomas,et al.  The conformation of methyl 4,6-O-(S)-benzylidene-2-chloro-2-deoxy-α-D-idopyranoside in the crystalline state and in chloroform solution , 1981 .

[17]  P. Luger,et al.  Konformationsanalyse, XXII. Twist‐Boat‐Konformation von Methyl‐2,3,4‐tri‐O‐benzoyl‐β‐D‐xylopyranosid im Kristall , 1980 .

[18]  F. D. Leeuw,et al.  The relationship between proton-proton NMR coupling constants and substituent electronegativities—I : An empirical generalization of the karplus equation , 1980 .

[19]  F. Radaelli,et al.  Correlation of sulfate content and degree of carboxylation of heparin and related glycosaminoglycans with anticomplement activity. Relationships to the anticoagulant and platelet-aggregating activities. , 1979, Thrombosis research.

[20]  Å. Danielsson,et al.  The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies. , 1978, European journal of biochemistry.

[21]  G. A. Jeffrey,et al.  Application of ab initio molecular orbital calculations to the structural moieties of carbohydrates. 3 , 1978 .

[22]  G. A. Jeffrey,et al.  The crystal structure of 3‐amino‐1,6‐anhydro‐3‐deoxy‐β‐d‐glucopyranose by neutron diffraction , 1977 .

[23]  H. Paulsen,et al.  Konformation der 1,2,3,4,6-penta-O-acetyl-α-D-idopyranose im kristall , 1976 .

[24]  H. Sørum,et al.  Calcium sodium α-d-galacturonate hexahydrate , 1976 .

[25]  S. J. Angyal,et al.  The Composition and Conformation of Sugars in Solution , 1969 .

[26]  R. E. Rundle,et al.  Neutron Diffraction Study of Gypsum, CaSO42H2O , 1958 .